Back

Efficacy of PCSK9 inhibitors combined with statins versus statin monotherapy for secondary cardiovascular prevention: a systematic review and meta-analysis

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Maximiliano Lang

Pilar (Argentina)

6 More presentations in this session

Presentation thumbnail
Combination therapy rapidly improves symptoms and quality of life in recently diagnosed angina patients: the COMBINE Angina study
Professor M. Marzilli (Pisa, IT)
Abstract Slides
Presentation thumbnail
Efficacy and safety of selective serotonin reuptake inhibitors on cardiovascular outcomes of patients with post-acute coronary syndrome depression: a systematic review and meta-analysis
Doctor J. Magno (Angeles City, PH)
Abstract Slides
Presentation thumbnail
Colchicine in acute coronary syndromes: a meta-analysis of 12.602 patients
Associate Professor G. Liuzzo (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Association of colchicine with atrial fibrillation and safety outcomes in patients with acute coronary syndrome
Doctor M. Tao (Hartford, US)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of edoxaban monotherapy vs dual antithrombotic therapy in patients with stable coronary artery disease and non-valvular atrial fibrillation: a systematic review and meta-analysis
Doctor P. Go (Taguig, PH)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in coronary artery disease (2)

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Longer-term impact of PCSK9 inhibitors on major adverse cardiovascular events and all-cause mortality: a systematic review and meta-analysis of randomised controlled trials
thumbnail
Congress Presentation
Oral PCSK9 inhibitors as an emerging frontier in lipid management: a meta-analysis
thumbnail
Congress Presentation
Early initiation of PCSK9 inhibitor therapy versus placebo in patients with acute coronary syndrome: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources